Lumlertgul, Nuttha
Murugan, Raghavan
Seylanova, Nina
McCready, Patricia
Ostermann, Marlies http://orcid.org/0000-0001-9500-9080
Funding for this research was provided by:
La Jolla Pharmaceutical Company
Article History
Received: 19 June 2020
Accepted: 24 November 2020
First Online: 1 December 2020
Ethics approval and consent to participate
: The project was approved by the Institutional Review Board of the University of Pittsburgh (PRO17100636). According to the federal regulations [ยง45 CFR 46.102(f)], explicit written or verbal consent was not required. Consent was implied upon completion of survey. The project was endorsed by the European Society of Intensive Care Medicine (ESICM), the National Institute of Health Research in the United Kingdom and the respective national approval committees.
: Not applicable.
: RM reports grants from La Jolla, Bioporto, and are site investigators for La Jolla and Am Pharma, all of which are outside the submitted work. Others declare no competing interests.